Hossein Ghanbarian

Hossein Ghanbarian

Auto-generated profile, based on publicly available information

Hossein Ghanbarian

Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Life Sciences
Verified
Journal Article
Closed access
ZBZohreh Bolandi
Zohreh Bolandi
NMNeda Mokhberian
Neda Mokhberian
MEMohamad Eftekhary
Mohamad Eftekhary
KSKazem Sharifi
Kazem Sharifi
SSSara Soudi
Sara Soudi
SHSeyed Mahmoud Hashemi
Seyed Mahmoud Hashemi

12 March 2018 in Biomacromolecules
Verified
Journal Article
Closed access
MGMazaher Gholipourmalekabadi
Mazaher Gholipourmalekabadi
Alexander Marcus SeifalianAlexander Marcus Seifalian
Alexander Marcus Seifalian
AUAleksandra M. Urbanska
Aleksandra M. Urbanska
MOMir Davood Omrani
Mir Davood Omrani
JHJohn G. Hardy
John G. Hardy
Ali SamadikuchaksaraeiAli Samadikuchaksaraei
Ali Samadikuchaksaraei

1 September 2021 in Pharmacological Research
Verified
Journal Article
Closed access
SAShahin Aghamiri
Shahin Aghamiri
FZFarshid Zandsalimi
Farshid Zandsalimi
PRPourya Raee
Pourya Raee
MAMohammad-Amin Abdollahifar
Mohammad-Amin Abdollahifar
STShing Cheng Tan
Shing Cheng Tan
MBMojgan Bandehpour
Mojgan Bandehpour

19 December 2016 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
MDMaryam Daneshpour
Maryam Daneshpour
KOKobra Omidfar
Kobra Omidfar
HGHossein Ghanbarian
Hossein Ghanbarian
Gastric cancer (GC) is the second leading cause of cancer-related deaths all over the world. miR-106a is a circulatory oncogenic microRNA (miRNA), which overexpresses in various malignancies, especially in GC. In this study, an ultrasensitive electrochemical nanobiosensor was developed for the detection of miR-106a using a double-specific probe methodology and a gold–magnetic nanocomposite as tracing tag. The successful modification of the electrode and hybridization with the target miRNA were confirmed by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) methods. Differential pulse voltammetry (DPV) was used for quantitative evaluation of miR-106a via recording the reduction peak current of gold nanoparticles. The electrochemical signal had a linear relationship with the concentration of the target miRNA ranging from 1 × 10−3pM to 1 × 103pM, and the detection limit was 3 × 10−4pM. The proposed miRNA-nanobiosensor showed remarkable selectivity, high specificity, agreeable storage stability, and great performance in real sample investigation with no pretreatment or amplification. Consequently, our biosensing strategy offers such a promising application to be used for clinical early detection of GC and additionally the screen of any miRNA sequence.

8 March 2021 in Cells
Verified
Journal Article
Open access
PDF file
HGHossein Ghanbarian
Hossein Ghanbarian
SAShahin Aghamiri
Shahin Aghamiri
MEmohamad eftekhary
mohamad eftekhary
Nicole WagnerNicole Wagner
Nicole Wagner
Kay-Dietrich WagnerKay-Dietrich Wagner
Kay-Dietrich Wagner
Small double-strand RNA (dsRNA) molecules can activate endogenous genes via an RNA-based promoter targeting mechanism. RNA activation (RNAa) is an evolutionarily conserved mechanism present in diverse eukaryotic organisms ranging from nematodes to humans. Small activating RNAs (saRNAs) involved in RNAa have been successfully used to activate gene expression in cultured cells, and thereby this emergent technique might allow us to develop various biotechnological applications, without the need to synthesize hazardous construct systems harboring exogenous DNA sequences. Accordingly, this thematic issue aims to provide insights into how RNAa cellular machinery can be harnessed to activate gene expression leading to a more effective clinical treatment of various diseases.

8 February 2020 in BioImpacts
Verified
Journal Article
Open access
PDF file
MKMaryam Sadat Khoramgah
Maryam Sadat Khoramgah
JRJavad Ranjbari
Javad Ranjbari
HAHojjat Allah Abbaszadeh
Hojjat Allah Abbaszadeh
FMFatemeh Sadat Tabatabaei Mirakabad
Fatemeh Sadat Tabatabaei Mirakabad
SHShadie Hatami
Shadie Hatami
HGHossein Ghanbarian
Hossein Ghanbarian
Introduction: Simulating hydrophobic-hydrophilic composite face with hierarchical porous and fibrous architectures of bone extracellular matrix (ECM) is a key aspect in bone tissue engineering. This study focused on the fabrication of new three-dimensional (3D) scaffolds containing polytetrafluoroethylene (PTFE), and polyvinyl alcohol (PVA), with and without graphene oxide (GO) nanoparticles using the chemical cross-linking and freeze-drying methods for bone tissue application. The effects of GO on physicochemical features and osteoinduction properties of the scaffolds were evaluated through an in vitro study. Methods: After synthesizing the GO nanoparticles, two types of 3D scaffolds, PTFE/PVA (PP) and PTFE/PVA/GO (PPG), were developed by cross-linking and freeze-drying methods. The physicochemical features of scaffolds were assessed and the interaction of the 3D scaffold types with human adipose mesenchymal stem cells (hADSCs) including attachment, proliferation, and differentiation to osteogenic like cells were investigated. Results: GO nanoparticles were successfully synthesized with no agglomeration. The blending of PTFE as a hydrophobic polymer with PVA polymer and GO nanoparticles (hydrophilic compartments) were successful. Two types of 3D scaffolds had nano topographical structures, good porosities, hydrophilic surfaces, thermal stabilities, good stiffness, as well as supporting the cell attachments, proliferation, and osteogenic differentiation. Notably, GO incorporating scaffolds provided a better milieu for cell behaviors. Conclusion: Novel multiscale porous nanofibrous 3D scaffolds made from PTFE/ PVA polymers with and without GO nanoparticles could be an ideal candidate for bone tissue engineering as a 3D template.